11th November 2020

Biocatalysts Ltd Continuing to Work in the ‘New Normal’

Author: Carolyn Pritchard
Role: Technical Marketing Manager

During this very trying year for everyone, Biocatalysts Ltd have continued to manufacture and supply our range of speciality enzymes, launch new products LipomodTM 888MDP, LipomodTM 767P and most recently Proteocut K. Our Business Managers have been available to speak to their customers and we have attended virtual exhibitions, conferences and summits giving presentations and listening to what the key trends and issues are in the food and biotech related industries.

Now that the immediate questions of continuity of supply and supporting our customers requirements have been answered, both ourselves and our customers have found ways to keep new product development projects on track and even start new projects. Innovation is key to the growth and development of any business. It is at the heart of what we do at Biocatalysts Ltd and we continue to be able to offer our award-winning enzyme discovery, development and manufacturing service to kick-start your businesses innovation projects. We are also finishing the validation our NEW world-class enzyme manufacturing facility and are looking forward to further scale up our many exciting projects.

For the remainder of the year, our technical and commercial team will be in attendance at a number of virtual events both in Europe and the US. Where they will be more than happy to arrange 1-2-1 meetings to discuss how Biocatalysts’ products and services can provide solutions across a variety of industries from food, to life science and pharmaceuticals. Below is a list of meetings we will be attending hope to see you there – virtual!

• Medica, 16 – 19 November
• Applied Biocatalysis Summit, 17- 18 November
• FiE Connect, 24 November – 4 December
• Protein Engineering Congress EU, 1 December
• Future Food Technology, 2- 3 December